Philips CPAP Machine Recall Lawsuits

In June 2021, Philips Respironics recalled millions of continuous positive airway pressure (CPAP), bi-level positive airway pressure (BiPAP), and mechanical ventilator devices. The reason was a component most users had never heard of: a polyester-based polyurethane (PE-PUR) sound-abatement foam, placed inside the devices to reduce noise, that could break down and release particles and chemicals into the air that patients breathed each night. The recall eventually affected roughly 15 million devices worldwide, and it launched what has become one of the most significant medical-device mass tort proceedings in recent memory.

For patients who used these devices — often nightly, for years — the questions that followed were urgent and personal. What had they inhaled? Were the cancers, respiratory conditions, and other illnesses they developed connected to the machines? Were they eligible for compensation? And if so, what did that process actually look like?

This guide explains the Philips CPAP recall and the resulting litigation in plain language. It covers why the recall happened, the health conditions named in the lawsuits, the structure of the federal multidistrict litigation (MDL 3014), the major settlement agreements, who may qualify, what evidence matters, and what current deadlines and developments look like for new claimants. For readers new to product liability proceedings, the overview page on mass torts explains how these large-scale cases are structured and how they differ from ordinary class actions. For anyone who used a recalled Philips device, understanding the factual and procedural landscape is the starting point for evaluating legal options.

A note on scope. CredibleLaw is a national legal resource and attorney referral network. It is not a law firm, and nothing in this article is legal advice or medical advice. Health decisions should be made with a qualified medical professional. Eligibility for any lawsuit or settlement program depends on specific facts, medical records, and deadlines, which must be reviewed by licensed counsel.

Why Philips CPAP Machines Were Recalled

The Philips recall centered on the sound-abatement foam inside the affected devices. The foam — polyester-based polyurethane, or PE-PUR — was chosen to reduce the noise and vibration of the machines during use. In 2021, Philips acknowledged that this foam could degrade, particularly in hot and humid conditions, and that degradation could allow two things to happen inside the sealed air pathway of the device.

• Particulate exposure. Small black pieces of degraded foam could enter the air tubes and be inhaled or swallowed by the patient. In some cases, users reported seeing dark debris in the mask or tubing. In others, the particles were not visible to the eye.
• Chemical exposure. The foam could also release volatile organic compounds (VOCs) and other chemicals into the air the patient breathed. Philips’ own recall notice identified potential risks including irritation, inflammation, respiratory issues, and possible toxic and carcinogenic effects.

The U.S. Food and Drug Administration (FDA) classified the recall as Class I — its most serious category, reserved for situations in which use of the product may cause serious injury or death. The agency subsequently issued multiple safety communications updating patients and providers on the evolving concerns and on the medical device reports (MDRs) it was receiving.

In January 2024, the FDA reported that it had received more than 116,000 MDRs reportedly associated with the foam breakdown since April 2021, including 561 reports of death. The FDA has been careful to note that MDRs are reports of suspected association and do not necessarily establish that any device caused a specific outcome. Still, the scale and clinical profile of those reports drew significant attention from regulators, clinicians, and patients.

Health Conditions Linked to Recalled CPAP Machines

Across the litigation and the FDA’s own reporting, a consistent set of health concerns has emerged. Not every user of a recalled device will develop these conditions, and not every diagnosed condition is attributable to device exposure. But the conditions named most frequently in Philips CPAP lawsuits and in medical device reports fall into several clusters.

Respiratory and airway conditions

Users have reported airway irritation, chronic cough, reactive airway disease, chest pressure, pneumonia, sinus infection, and related pulmonary complications. Lawsuits have also raised concerns about pulmonary fibrosis — scarring of lung tissue — and acute respiratory distress syndrome in more severe cases.

Cancers

Plaintiffs have alleged a range of cancers potentially linked to long-term exposure to degraded foam particles and off-gassed chemicals, including lung cancer, kidney cancer, liver cancer, bladder cancer, and several others identified in the master complaints and related filings. The scientific literature on PE-PUR foam exposure and specific cancer risk is still developing, and causation in any individual case is a question for medical and legal review.

Organ damage and systemic effects

Reports have also raised concerns about kidney and liver effects consistent with chemical exposure, as well as headaches, dizziness, nausea, and other systemic symptoms associated with the off-gassing pathway.

General symptoms during use

At the less severe end of the spectrum, many users reported headache, upper airway irritation, cough, and sinus inflammation that appeared or worsened during the period of device use. These lower-severity symptoms do not necessarily establish a personal injury claim on their own, but they appear frequently in the MDR database.

Philips CPAP Lawsuits Explained

The lawsuits filed against Philips Respironics and affiliated entities fall broadly into two tracks: personal injury claims and economic loss claims. Both were consolidated within the federal multidistrict litigation known as MDL 3014 — formally, In re Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Litigation — which was established in the U.S. District Court for the Western District of Pennsylvania before Judge Joy Flowers Conti. For broader background on how mass tort lawsuits are organized, consolidated, and resolved, the referenced overview covers the general procedural framework that the Philips CPAP litigation operates within.

Personal injury claims

Personal injury plaintiffs allege that they suffered specific health injuries from using recalled devices. The legal theories in these cases typically include design defect (arguing that the use of PE-PUR foam in a device channeling air to patients was itself unreasonably dangerous), manufacturing defect, failure to warn (arguing that Philips knew or should have known about the foam’s degradation risks and did not adequately warn users or regulators in time), negligence, and breach of warranty.

Economic loss class actions

Economic loss plaintiffs brought claims focused on the financial harm from purchasing or renting recalled devices. These claims did not require a personal injury diagnosis. They focused instead on the diminished value of the devices, replacement and repair costs, and related economic harms suffered by consumers, payers, and insurers.

Medical monitoring

A separate medical monitoring track addressed the costs of monitoring for future health effects among users who may have been exposed but had not yet developed a specific injury. This track was resolved as part of the broader 2024 settlement structure described below.

Philips CPAP Lawsuit Settlements: $479 Million and $1.1 Billion

The Philips CPAP litigation has produced two major settlement tracks. Both were approved under the supervision of the MDL court. Together, they represent the most significant publicly reported resolutions in the litigation to date.

Economic loss settlement — at least $479 million

The economic loss class action settlement, which received preliminary approval in October 2023 and final approval on April 25, 2024, was valued at a minimum of $479 million. It resolved claims related to the financial harm from the recall — reimbursement to users and payers who had purchased or leased recalled devices, along with additional incentives for device return by specified deadlines.

Personal injury and medical monitoring settlement — $1.1 billion

On April 29, 2024, Philips announced a $1.1 billion settlement to resolve personal injury and medical monitoring claims in the United States. The settlement allocates $1.075 billion to compensate eligible personal injury claimants and $25 million for medical monitoring. The Personal Injury Master Settlement Agreement was executed on May 9, 2024. Philips did not admit fault or liability, and the settlement framework established a structured compensation program administered outside of individual trials.

Eligibility for the personal injury settlement program was tied to specific registration and documentation steps, including a registration deadline of January 31, 2025 for represented claimants and related deadlines for pro se claimants. Rolling payments to eligible claimants have been proceeding through 2025 and into 2026, with Medicare lien resolution being a common source of timing delays for individual distributions.

Consent decree

Separately, on April 9, 2024, a federal district court entered a consent decree against Philips Respironics that included provisions aimed at prioritizing patient relief and ensuring regulatory compliance, including implementation of a Recall Remediation Plan agreed to with the FDA.

Who May Qualify for a Philips CPAP Lawsuit

Eligibility depends on whether a claim is brought through the active settlement programs, through the remaining MDL cases, or outside them. In general terms, the factors that tend to matter most include:

• Use of a recalled device. Documented use of a Philips CPAP, BiPAP, or mechanical ventilator identified in the June 2021 recall. Device model, serial number, and usage period typically need to be established.
• A qualifying injury. A documented medical diagnosis falling within categories recognized by the settlement program or supportable as a product liability claim, such as specific cancers, respiratory conditions, or organ damage.
• Temporal alignment. A plausible time relationship between device exposure and diagnosis, typically requiring medical records covering both the period of use and the development of the injury.
• Timely registration or filing. Meeting applicable deadlines — both within the established settlement programs (where open) and under state statutes of limitations and repose for any claims pursued outside those programs.
• Documentation. Records showing purchase, rental, or use of the device; the recall notice; medical records; and communication with Philips or a durable medical equipment supplier.

Claimants who received diagnoses more recently — for example, a new cancer diagnosis in 2024, 2025, or 2026 after years of device use — may still have legal options, but the available pathways depend heavily on whether the settlement programs remain open to new entrants and on state-specific statutes of limitations. Each situation should be reviewed individually. Readers evaluating other current product liability proceedings can also review CredibleLaw’s list of active mass torts to see whether other devices, medications, or products they have used are currently under litigation.

Recalled Philips CPAP, BiPAP, and Ventilator Models

The 2021 recall covered a wide range of Philips Respironics devices. The commonly named device families include:

• DreamStation CPAP and BiPAP devices — one of the most widely distributed lines affected by the recall.
• System One CPAP and BiPAP devices — an earlier generation line also implicated.
• DreamStation Go — portable devices commonly used by travelers.
• Dorma 400, 500, and REMstar series — additional CPAP and BiPAP lines included in the recall.
• Mechanical ventilators — including the Trilogy 100/200, Garbin Plus, Aeris, LifeVent, and A-Series BiPAP ventilator models.

A complete model list is maintained on the FDA’s recall page and on Philips’ own recall resources. Users who are unsure whether their device is affected should compare the device’s model number and serial number against the published recall list rather than relying on the device name alone.

Evidence Used in CPAP Lawsuits

Documentation is the backbone of any Philips CPAP claim. The stronger and more complete the record, the faster and more favorably a claim tends to be evaluated. Typical categories of evidence include:

• Device records. Purchase receipts, rental agreements, durable medical equipment supplier records, model and serial numbers, and the recall notification received from Philips or the supplier.
• Medical records. Records showing prescription of CPAP or BiPAP therapy, the sleep study or diagnosis that prompted treatment, and records documenting the development of any injury claimed in the case.
• Usage documentation. Data downloaded from the device (where still available), pharmacy or supply records showing ongoing mask and filter purchases, and insurance records showing device-related claims.
• Symptom and treatment history. Clinical notes documenting respiratory complaints, diagnostic imaging, biopsy or pathology reports, oncology treatment records, and related care.
• Communications. Any correspondence with Philips, the device supplier, or the prescribing provider about the recall, device replacement, or continued use.

What Compensation May Cover

Personal injury claims in the Philips CPAP litigation are typically framed around categories of damages common to product liability cases generally. Actual amounts vary significantly by the specific settlement framework, the severity of injury, and the individual facts.

• Medical expenses. Past and reasonably anticipated future medical costs related to the claimed injury, including diagnostic testing, treatment, medications, surgery, and supportive care.
• Lost wages and earning capacity. Income lost during treatment and, in more severe cases, diminished earning capacity over time.
• Pain and suffering. Non-economic damages for physical pain, emotional distress, and reduced quality of life.
• Loss of consortium. Where applicable under state law, claims by spouses for loss of companionship and related harms.
• Wrongful death damages. In fatal cases, statutory wrongful death claims brought by eligible family members, typically including funeral and burial costs, loss of financial support, and related losses.
• Medical monitoring. Coverage of appropriate screening and surveillance for users who may have been exposed but have not yet developed a specific diagnosis.

What to Do If You Used a Recalled Philips CPAP Machine

Recommended Next Steps 1. Verify the device. Check model and serial number against the official FDA recall list and Philips’ recall resources. 2. Talk to a physician before changing therapy. Sleep apnea is a serious condition; do not discontinue a prescribed device without consulting the prescribing clinician. This applies especially to ventilator users. 3. Document symptoms and diagnoses. Make sure any relevant symptoms have been discussed with and recorded by treating providers. 4. Preserve the device if possible. Where safe and practical — and where the device has not already been returned under the recall — preservation can support documentation. 5. Gather records. Purchase and rental records, the recall notice, sleep study reports, and medical records relevant to any claimed injury. 6. Speak with a lawyer familiar with mass tort product liability and the Philips CPAP proceedings to evaluate eligibility and deadlines.

Philips CPAP Recall and Litigation Timeline

The timeline below summarizes the major events in the Philips CPAP recall and the resulting litigation. Exact dates and milestones are drawn from FDA safety communications, MDL 3014 court filings, official settlement resources, and Philips’ own regulatory disclosures.

Date	Event
June 14, 2021	Philips Respironics announces the recall of certain CPAP, BiPAP, and mechanical ventilator devices containing PE-PUR sound-abatement foam.
October 8, 2021	The Judicial Panel on Multidistrict Litigation establishes MDL 3014 in the Western District of Pennsylvania before Judge Joy Flowers Conti.
2022–2023	Discovery, case-management orders, fact-sheet procedures, and related pretrial activity proceed in MDL 3014. The FDA reclassifies and issues updates regarding the recall.
September 7, 2023	Motion filed for preliminary approval of the economic-loss class action settlement; preliminary approval granted October 10, 2023.
April 9, 2024	A federal district court enters a consent decree against Philips Respironics, including provisions for a Recall Remediation Plan.
April 25, 2024	Final approval of the economic-loss class action settlement of at least $479 million.
April 29, 2024	Philips announces a $1.1 billion settlement to resolve personal injury and medical monitoring claims (comprising $1.075 billion for personal injury and $25 million for medical monitoring).
May 9, 2024	Personal Injury Master Settlement Agreement executed.
January 31, 2025	Registration deadline for represented claimants to participate in the personal injury settlement program.
2025–2026	Claims processing and rolling payments proceed through the settlement program; a small number of opt-out and related individual cases remain in the MDL.

Philips CPAP Lawsuit: Frequently Asked Questions

What is the Philips CPAP recall?

The Philips CPAP recall refers to the June 2021 recall by Philips Respironics of certain CPAP, BiPAP, and mechanical ventilator devices containing polyester-based polyurethane (PE-PUR) sound-abatement foam. The foam could degrade and release particles and chemicals into the air pathway of the device. The FDA classified the recall as Class I, the most serious category.

Do I qualify for a Philips CPAP lawsuit?

Eligibility depends on documented use of a recalled device, a qualifying medical diagnosis, temporal alignment between use and diagnosis, and applicable deadlines (including settlement program registration windows and state statutes of limitations). Only a qualified attorney reviewing your specific records can provide an eligibility assessment.

Can CPAP machines cause cancer?

Philips’ own recall notice acknowledged that exposure to degraded PE-PUR foam carried potential toxic and carcinogenic effects. Lawsuits have named multiple cancers as alleged outcomes of long-term exposure. Scientific research on cancer risk from PE-PUR foam exposure is ongoing, and causation in any specific case is a clinical and legal question that depends on individual facts.

What is the Philips CPAP lawsuit settlement?

The major publicly reported settlements are the economic loss class action settlement of at least $479 million (final approval in April 2024) and the $1.1 billion personal injury and medical monitoring settlement announced in April 2024. The $1.1 billion figure consists of $1.075 billion for personal injury claims and $25 million for medical monitoring.

Is the Philips CPAP lawsuit still open?

The MDL remains active with a residual caseload, and payments continue to flow to registered settlement claimants. Whether a new claim can still be filed depends on the specific settlement program rules, applicable state statutes of limitations, and the individual facts. These questions should be reviewed promptly with qualified counsel because deadlines continue to matter. CredibleLaw also tracks emerging mass tort investigations that may affect users of other recalled or defective products.

How long do CPAP lawsuits take?

In traditional product liability litigation, individual cases can take years. Within the Philips settlement programs, the structured framework is designed to resolve eligible claims more quickly than full litigation, but rolling payments can still take many months due to claim review, documentation, and Medicare or other lien resolution.

How much do CPAP lawyers charge?

Mass tort and product liability attorneys typically work on a contingency fee basis, meaning they are paid a percentage of any recovery and do not charge up-front fees. Specific rates and terms are set by the attorney-client agreement and by any applicable court-approved fee structure in the MDL or settlement program.

What if a family member died while using a recalled device?

Statutory wrongful death claims may be available to eligible family members, with the specific eligibility and damages defined by state law. These claims are time-sensitive and require prompt consultation with counsel who handle mass tort and wrongful death matters.

Authoritative Resources

For readers seeking primary sources on the recall and litigation, the following official resources are referenced throughout this article:

• U.S. Food and Drug Administration — recall page for Recalled Philips Ventilators, BiPAP Machines, and CPAP Machines and related safety communications.
• U.S. District Court for the Western District of Pennsylvania — MDL 3014 In re Philips Recalled CPAP, BI-LEVEL PAP, and Mechanical Ventilator Products Litigation.
• Official personal injury settlement website — Philips Respironics Personal Injury Settlement, which publishes current deadlines and claim procedures.
• U.S. Judicial Panel on Multidistrict Litigation — information on MDL proceedings generally at jpml.uscourts.gov.
• American Thoracic Society and peer-reviewed respiratory medicine sources — useful for clinical background on the respiratory conditions discussed in the litigation.

Speak With a Philips CPAP Lawsuit Attorney

Anyone who used a recalled Philips CPAP, BiPAP, or mechanical ventilator device and subsequently developed a serious respiratory condition, cancer, organ damage, or other significant health issue may have legal options worth exploring. The same is true for families whose loved ones died after using a recalled device.

The Philips CPAP litigation is complex, with multiple settlement tracks, specific registration procedures, and deadlines that continue to matter in 2026. Evaluating eligibility requires a careful review of device and medical records and a realistic assessment of which pathway — settlement program, remaining MDL cases, or state court — best fits the facts.

CredibleLaw maintains a national referral network of attorneys who handle mass tort product liability matters, including Philips CPAP claims. Readers can learn more about CredibleLaw and its referral model, or call (888) 201-0441 to request a free, confidential case review. There is no fee to speak with an attorney about eligibility.

Informational resource, not legal advice. CredibleLaw is a national legal resource and attorney referral network. This article is provided for educational and informational purposes only and does not create an attorney-client relationship. Nothing here is medical advice; medical decisions should be made with a qualified healthcare professional. Eligibility, deadlines, and outcomes vary significantly based on individual facts.